JP2025506381A - 胸腺間質性リンパ球新生因子に結合するタンパク質ｚバリアント及びそれらの医療的な使用 - Google Patents

胸腺間質性リンパ球新生因子に結合するタンパク質ｚバリアント及びそれらの医療的な使用 Download PDF

Info

Publication number
JP2025506381A
JP2025506381A JP2024545909A JP2024545909A JP2025506381A JP 2025506381 A JP2025506381 A JP 2025506381A JP 2024545909 A JP2024545909 A JP 2024545909A JP 2024545909 A JP2024545909 A JP 2024545909A JP 2025506381 A JP2025506381 A JP 2025506381A
Authority
JP
Japan
Prior art keywords
tslp
binding
sequence
seq
binding polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024545909A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506381A5 (https=
Inventor
エドバルドソン アンナ
ギュードムンツドッテル リンドビ
キジャーニ シアバシュ
クリント スサン
Original Assignee
アフィボディ アクティエボラーグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アフィボディ アクティエボラーグ filed Critical アフィボディ アクティエボラーグ
Publication of JP2025506381A publication Critical patent/JP2025506381A/ja
Publication of JP2025506381A5 publication Critical patent/JP2025506381A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2024545909A 2022-02-08 2023-02-08 胸腺間質性リンパ球新生因子に結合するタンパク質ｚバリアント及びそれらの医療的な使用 Pending JP2025506381A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22155646 2022-02-08
EP22155646.7 2022-02-08
PCT/EP2023/053030 WO2023152144A1 (en) 2022-02-08 2023-02-08 Protein z variants binding thymic stromal lymphopoietin and their medical use

Publications (2)

Publication Number Publication Date
JP2025506381A true JP2025506381A (ja) 2025-03-11
JP2025506381A5 JP2025506381A5 (https=) 2026-02-17

Family

ID=80682629

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024545909A Pending JP2025506381A (ja) 2022-02-08 2023-02-08 胸腺間質性リンパ球新生因子に結合するタンパク質ｚバリアント及びそれらの医療的な使用

Country Status (10)

Country Link
EP (1) EP4476247A1 (https=)
JP (1) JP2025506381A (https=)
KR (1) KR20240139058A (https=)
CN (1) CN118632866A (https=)
AR (1) AR128475A1 (https=)
AU (1) AU2023218534A1 (https=)
CA (1) CA3251231A1 (https=)
IL (1) IL314458A (https=)
MX (1) MX2024009732A (https=)
WO (1) WO2023152144A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2190863B1 (en) 2007-07-31 2015-09-02 Affibody AB New albumin binding compositions, methods and uses
ES2373832T3 (es) 2007-12-19 2012-02-09 Affibody Ab Polipéptido derivado de proteína a y capaz de unirse a pdgf.
CN103003296A (zh) 2010-07-09 2013-03-27 阿菲博迪公司 多肽
WO2014048977A1 (en) 2012-09-25 2014-04-03 Affibody Ab Albumin binding polzpeptide
KR102399024B1 (ko) 2014-06-13 2022-05-17 애피바디 에이비 신규 폴리펩티드
EP3245224B1 (en) * 2015-01-12 2020-07-15 Affibody AB Il-17a-binding polypeptides
CN108290931A (zh) 2015-10-30 2018-07-17 阿菲博迪公司 对pd-l1具有亲和力的新的多肽
WO2021089695A1 (en) * 2019-11-05 2021-05-14 Affibody Ab Polypeptides

Also Published As

Publication number Publication date
AR128475A1 (es) 2024-05-15
WO2023152144A1 (en) 2023-08-17
CA3251231A1 (en) 2023-08-17
EP4476247A1 (en) 2024-12-18
KR20240139058A (ko) 2024-09-20
MX2024009732A (es) 2024-08-19
IL314458A (en) 2024-09-01
AU2023218534A1 (en) 2024-07-11
CN118632866A (zh) 2024-09-10

Similar Documents

Publication Publication Date Title
EP2086998B1 (en) Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof
CN105555310B (zh) 一种提高蛋白血清半衰期的组合物和方法
KR102149028B1 (ko) 인간 보체 c5에 결합하는 폴리펩티드
KR20170123315A (ko) Tslp 결합 단백질
KR20100098697A (ko) 폐 전달을 위한 조성물
JP2013518853A (ja) 血清アルブミンと結合することが可能なペプチド並びにこれを含む化合物、構築物及びポリペプチド
JP2021073174A (ja) Ｉｌ−１７ａ結合ポリペプチド
WO2021017071A1 (zh) 抗人st2抗体及其用途
EP3038633B1 (en) Stable polypeptides binding to human complement c5
US20250066451A1 (en) Il-ir-i binding polypeptide
WO2023035272A1 (zh) 一种il17抗体及其制备方法和应用
CN106488930B (zh) 新型多肽
JP2025506381A (ja) 胸腺間質性リンパ球新生因子に結合するタンパク質ｚバリアント及びそれらの医療的な使用
JP2026508149A (ja) イヌｉｌ－１３に対するイヌ抗体
US20220389066A1 (en) Polypeptides
CN116547006A (zh) 抗pd-l1纳米抗体及其应用
TW202511284A (zh) 包含robo結構域的蛋白及其醫藥用途
JP2026506599A (ja) イヌｉｌ－４に対するイヌ抗体
WO2025219585A1 (en) Vhh antibodies which bind to canine albumin
CN121159685A (zh) 一种抗il-33的单域抗体及其用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260206